Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
SESerina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER)

New York Stock Exchange Arca · Currency in USD
$1.65 ▼ -0.11 (-6.25%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$1.76
Open
$1.76
Day's Range
$1.65 – $1.76
52 Week Range
$1.22 – $5.25
Volume
8,001
Avg. Volume
62,013
Market Cap
$24.75M
Beta (5Y Monthly)
0.03
PE Ratio (TTM)
--
EPS (TTM)
-$1.29
Earnings Date
Nov 18, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Serina Therapeutics, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
16
CEO
Steven A. Ledger

Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy.

Earnings

Next report: Wed, Nov 18, 2026
EPS estimate -$0.34
DateEst.Actual
Aug 13, 2026-$0.47-$0.55Miss
May 14, 2026-$0.44-$0.58Miss
Mar 23, 2026-$0.50-$0.31Beat
Nov 13, 2025-$0.47-$0.45Beat
Aug 11, 2025-$0.36-$0.66Miss
May 8, 2025-$0.62-$0.49Beat

Analyst view

Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on SER and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.